A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the ...

Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...

Much of pancreatic cancer’s evasive and deadly nature may come down to low levels of one gene. In A Nutshell Early detection, ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs that are initially effective lose their potency over time, as malignant ...

The gene p53 acts as a tumor suppressor and often is called the ‘guardian of the genome.’ This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading ...

Genetic testing showed that childhood cancer survivors aged faster biologically, regardless of the treatment they received as ...

About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...

The drug is not considered a cure, but results emerging from clinical trials point to the first major advancement in decades ...